OTTAWA, Dec. 7, 2016 /CNW/ – Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today’s award by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative agreement funding…
KANATA, ON, Nov. 8, 2016 /CNW/ – Nordion and Bruce Power have entered into an agreement to secure the long-term supply of Cobalt-60 up to 2064.
The agreement extends a previous supply arrangement that would have expired at the end of 2028 and now covers the life of the four Bruce B reactors, which will operate up to 2064 once life-extension maintenance programs are completed over the next two decades. The agreement also includes the supply of medical-grade ‘High Specific Activity’ (HSA) Cobalt…
Sterigenics International and its Subsidiary Nordion Enter into Agreement to Acquire REVISS Services
KANATA, ON – August 16, 2016 – Sterigenics International LLC and subsidiary Nordion are pleased to announce that they have entered into an agreement as part of REVISS’s Solvent Members Voluntary Liquidation to purchase REVISS Services (UK) Limited…
The role of Nordion technology in preventing the spread of the Zika virus
According to the International Atomic Energy Agency (IAEA), the global effort to combat the spread of the Zika virus is to include an important role for Cobalt-60, an isotope supplied by Nordion and produced in Bruce Power reactors.
April 4, 2016 – The Zika virus has been linked to birth defects, paralysis (Guillain-Barré syndrome) and, more recently, to a life-threatening type of brain inflammation…
Sterigenics International and Nordion welcome landmark agreement from Bruce Power and Ontario’s Independent Electricity System Operator to extend the life of six reactors, enabling continued long-term supply of Cobalt-60
Cobalt-60 is essential to the global healthcare community and this announcement showcases Ontario’s continued leadership in gamma sterilization
TORONTO – DEC. 4, 2015 – Sterigenics International LLC and subsidiary Nordion welcome the joint announcement from Bruce Power and Ontario’s Independent Electricity System Operator (IESO) to refurbish six of Ontario’s nuclear reactors…
Developing a new source of Cobalt-60 essential to global healthcare providers and patients
TORONTO – OCT. 27, 2015 – Two of Ontario’s innovative nuclear sector companies are once again building on their strong partnership and respective strengths to create a new, long-term supply of an important cancer-treating isotope, Cobalt-60, that will benefit healthcare patients in Canada and around the world…
Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes
Funding supports Nordion’s collaboration with General Atomics and the University of Missouri Research Reactor Center to produce a new, reliable source of medical isotopes
OTTAWA, Canada, September 30, 2015 – Nordion, a standalone business within Sterigenics International, welcomes today’s announcement by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) to award $9.7M…
Nordion welcomes 10 year operating license renewal
Canadian Nuclear Safety Commission approves ten-year license renewal for Ottawa, Ontario
nuclear substance processing facility
OTTAWA, Canada, September 30, 2015 — Nordion, a standalone business within Sterigenics International, today welcomed the Canadian Nuclear Safety Commission (CNSC) decision to renew the Nuclear Substance Processing Facility Operating License for the company’s Class 1B nuclear substance processing facility in Ottawa, Ontario…
Sterigenics International and Nordion announce landmark Canada-U.S. partnership agreement to provide a long-term, reliable supply of medical isotopes
New medical isotope supply agreements with U.S.-based MURR and General Atomics will serve patients in Canada, the U.S. and around the world.
OTTAWA (Feb 20, 2015) – – Sterigenics International LLC and subsidiary Nordion, announced today agreements with General Atomics and the University of Missouri Research Reactor Center (MURR®) to establish a new, reliable supply of medical isotopes…
Cobalt-60 is used to sterilize 40 per cent of the world’s single-use medical products and equipment
OTTAWA, November 14, 2014 – Nordion, a business unit of Sterigenics International LLC, is pleased to announce it has signed a multi-year agreement up to an additional 14-years with long-time partner Bruce Power…
